<?xml version="1.0"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.0//EN" "http://www.ncbi.nlm.nih.gov/entrez/query/static/PubMed.dtd">
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>barw</PublisherName>
      <JournalTitle>Judi Clinical Journal</JournalTitle>
      <Issn>3105-4102</Issn>
      <Volume>1</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="epublish">
        <Year>2025</Year>
        <Month>11</Month>
        <Day>12</Day>
      </PubDate>
    </Journal>
    <ArticleTitle>Preoperative Thyroglobulin and Thyroid Pathologies: A Single Center Experience</ArticleTitle>
    <FirstPage>71</FirstPage>
    <LastPage>75</LastPage>
    <ELocationID EIdType="doi">10.70955/JCJ.2025.9</ELocationID>
    <Language>eng</Language>
    <AuthorList>
      <Author>
        <FirstName> Shaho F. </FirstName>
        <LastName>Ahmed</LastName>
        <Affiliation>Endocrine Department, Shar Hospital, Malik Mahmud Ring Road, Sulaymaniyah, Iraq.</Affiliation>
      </Author>
      <Author>
        <FirstName>Rebaz  M. </FirstName>
        <LastName>Ali</LastName>
        <Affiliation>Oncology Department, Hiwa Cancer Hospi tal, Shorsh Street, Sulaymaniyah, Iraq</Affiliation>
      </Author>
      <Author>
        <FirstName>Rawa M.</FirstName>
        <LastName>Ali</LastName>
        <Affiliation>Department of Pathology, Hospital for Treatment of Victims of Chemical Weapons, Mawlawy  Street, Halabja, Iraq</Affiliation>
      </Author>
      <Author>
        <FirstName>Ari M. </FirstName>
        <LastName>Abdullah</LastName>
        <Affiliation>Department of Pathology, Sulaymaniyah Teaching Hospital, Zanko Street, Sulaymaniyah, Iraq</Affiliation>
      </Author>
      <Author>
        <FirstName>Abdulwahid  M.</FirstName>
        <LastName> Salih</LastName>
        <Affiliation>Scientific Affairs  Department, Smart Health Tower, Madam Mitterrand Street, Sulaymaniyah, Iraq</Affiliation>
      </Author>
      <Author>
        <FirstName>Hiwa O. </FirstName>
        <LastName>Baba</LastName>
        <Affiliation>Scientific Affairs  Department, Smart Health Tower, Madam Mitterrand Street, Sulaymaniyah, Iraq</Affiliation>
      </Author>
      <Author>
        <FirstName>Rebaz O. </FirstName>
        <LastName>Mohammed</LastName>
        <Affiliation>Scientific Affairs  Department, Smart Health Tower, Madam Mitterrand Street, Sulaymaniyah, Iraq</Affiliation>
      </Author>
      <Author>
        <FirstName>Aso N. </FirstName>
        <LastName>Qadir</LastName>
        <Affiliation>Scientific Affairs  Department, Smart Health Tower, Madam Mitterrand Street, Sulaymaniyah, Iraq</Affiliation>
      </Author>
      <Author>
        <FirstName>Shko H. </FirstName>
        <LastName>Hassan</LastName>
        <Affiliation>Zad Organization, Saeed Kaban Street, Judi tower,  Sulaymaniyah, Iraq</Affiliation>
      </Author>
      <Author>
        <FirstName> Abdullah A. </FirstName>
        <LastName>Qadir</LastName>
        <Affiliation>Scientific Affairs  Department, Smart Health Tower, Madam Mitterrand Street, Sulaymaniyah, Iraq</Affiliation>
      </Author>
      <Author>
        <FirstName>Harun A. </FirstName>
        <LastName>Ahmed</LastName>
        <Affiliation>Scientific Affairs  Department, Smart Health Tower, Madam Mitterrand Street, Sulaymaniyah, Iraq</Affiliation>
      </Author>
      <Author>
        <FirstName>Hawkar A. </FirstName>
        <LastName>Nasralla</LastName>
        <Affiliation>Scientific Affairs  Department, Smart Health Tower, Madam Mitterrand Street, Sulaymaniyah, Iraq</Affiliation>
      </Author>
      <Author>
        <FirstName>Berun A.</FirstName>
        <LastName>Abdalla</LastName>
        <Affiliation>Scientific Affairs  Department, Smart Health Tower, Madam Mitterrand Street, Sulaymaniyah, Iraq</Affiliation>
      </Author>
      <Author>
        <FirstName>Fahmi H. </FirstName>
        <LastName>Kakamad</LastName>
        <Affiliation>College of Medicine, University of Sulaimani, Madam Mitterrand Street, Sulaymaniyah, Iraq</Affiliation>
        <Identifier Source="ORCID">0000-0002-2124-9580</Identifier>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2025</Year>
        <Month>08</Month>
        <Day>26</Day>
      </PubDate>
    </History>
    <Abstract>Introduction: Thyroid nodules are frequently found in the general population, though malignancy is confirmed in only a minority of cases. Distinguishing between benign and malignant nodules before surgery is vital for appropriate clinical management. The utility of preoperative serum thyroglobulin (Tg) levels as a diagnostic marker in thyroid carcinomas remains controversial. This study aimed to provide a descriptive overview of patients with markedly elevated preoperative Tg levels (&gt;500 ng/mL) and their corresponding histopathological outcomes.

Methods: A retrospective, single-center study was conducted at Smart Health Tower, which included patients who underwent surgical interventions for thyroid disorders between 2019 and 2025, with preoperative serum Tg levels exceeding 500 ng/mL. Patients were excluded if they had incomplete medical records. Patient demographics, clinical features, preoperative findings, surgical details, and final histopathology were retrieved from electronic medical records.

Results: A total of 260 patients were included, predominantly female (73.08%), with a median age of 49 years (QR: 38&#x2013;61). Neck swelling was the most common symptom (63.08%). Ultrasonography showed follicular nodular disease in 60.0%. Fine-needle aspiration cytology revealed Bethesda II in 20.0%, IV in 13.85%, and VI in 11.15% of cases. Total thyroidectomy was performed in 74.62% of cases. Histopathology showed benign lesions in 70.77% and malignant lesions in 29.23% of the cases.

Conclusion: Preoperative Tg levels may be elevated in both benign and malignant thyroid disorders; however, Tg may not possess adequate diagnostic precision to be used as a sole indicator of malignancy.
</Abstract>
  </Article>
</ArticleSet>
